{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:32:51Z","timestamp":1772929971488,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.4158\/ep161407.dscr","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:01:29Z","timestamp":1468454489000},"page":"1235-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: Update on Growth Hormone Stimulation Testing and Proposed Revised Cut-Point for the Glucagon Stimulation Test in the Diagnosis Of Adult Growth Hormone Deficiency"],"prefix":"10.1016","volume":"22","author":[{"given":"Kevin C.J.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Tritos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP161407.DSCR_bb0010","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0015","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/ghir.2001.0263","article-title":"Growth hormone replacement therapy for adults: into the new millennium","volume":"12","author":"Simpson","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"10.4158\/EP161407.DSCR_bb0025","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency","volume":"21","author":"J\u00f8rgensen","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"10.4158\/EP161407.DSCR_bb0035","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1210\/jc.2008-1239","article-title":"The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a meta-analysis","volume":"93","author":"Widdowson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMp020186","article-title":"Can growth hormone prevent aging?","volume":"348","author":"Vance","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161407.DSCR_bb0045","first-page":"2013","article-title":"Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19\u201382 years, in relation to those in healthy subjects","volume":"84","author":"Hilding","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2265.2008.03201.x","article-title":"Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels","volume":"69","author":"Yuen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"suppl 2","key":"10.4158\/EP161407.DSCR_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161407.DSCR_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4158\/EP14603.OR","article-title":"Trends in growth hormone stimulation testing and growth hormone dosing in adult growth hormone deficiency patients: results from the ANSWER Program","volume":"22","author":"Gordon","year":"2016","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161407.DSCR_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-09-0824","article-title":"Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery","volume":"162","author":"Berg","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF03345251","article-title":"Glucagon stimulation test for the diagnosis of GH deficiency in adults","volume":"26","author":"Concei\u00e7\u00e3o","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161407.DSCR_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/eje.0.1420347","article-title":"Comparisons among old and new provocative tests of GH secretion in 178 normal adults","volume":"142","author":"Aimaretti","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","article-title":"The assessment of growth hormone status in normal young adult males using a variety of provocative agents","volume":"45","author":"Rahim","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0095","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1210\/jc.2014-2830","article-title":"Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid over-diagnosis of growth hormone deficiency","volume":"99","author":"Dichtel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ghir.2015.12.005","article-title":"Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease","volume":"26","author":"Wilson","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"10.4158\/EP161407.DSCR_bb0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11102-012-0407-7","article-title":"Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults","volume":"16","author":"Yuen","year":"2013","journal-title":"Pituitary"},{"key":"10.4158\/EP161407.DSCR_bb0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11102-016-0712-7","article-title":"Revised GH and cortisol cutpoints for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study","volume":"19","author":"Hamrahian","year":"2016","journal-title":"Pituitary"},{"key":"10.4158\/EP161407.DSCR_bb0115","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.4158\/EP161407.DSCR_bb0120","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1530\/EJE-09-0291","article-title":"Cardiovascular risk factors in hypopituitary GH-deficient adults","volume":"161","author":"Verhelst","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0125","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0130","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1210\/jc.2002-012006","article-title":"Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome","volume":"87","author":"Van Dam","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/hepr.12408","article-title":"Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease","volume":"45","author":"Sumida","year":"2015","journal-title":"Hepatol Res"},{"key":"10.4158\/EP161407.DSCR_bb0150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jc.2004-0501","article-title":"Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity","volume":"90","author":"Gleeson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0155","first-page":"6","article-title":"Individual IGF-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency","volume":"65","author":"Yuen","year":"2006","journal-title":"Horm Res"},{"key":"10.4158\/EP161407.DSCR_bb0160","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth-hormone deficiency in adults","volume":"343","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"key":"10.4158\/EP161407.DSCR_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2265.2008.03466.x","article-title":"Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery","volume":"71","author":"Lee","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.2001.01179.x","article-title":"Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men","volume":"54","author":"Pfeifer","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/eje.0.1330305","article-title":"Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test","volume":"133","author":"Hoeck","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/BF03347790","article-title":"Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity","volume":"17","author":"Ghigo","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161407.DSCR_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2002.01472.x","article-title":"Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults","volume":"56","author":"G\u00f3mez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2006.02569.x","article-title":"GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50\u201390","volume":"65","author":"Carmichael","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000341193","article-title":"Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline","volume":"5","author":"Mathus-Vliegen","year":"2012","journal-title":"Obes Facts"},{"key":"10.4158\/EP161407.DSCR_bb0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.2001.01169.x","article-title":"An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease","volume":"54","author":"Leong","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2265.1989.tb01276.x","article-title":"Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects","volume":"31","author":"Littley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2265.1998.00610.x","article-title":"Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST)","volume":"49","author":"Orme","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0215","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2009-0299","article-title":"Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?","volume":"94","author":"Yuen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ghir.2014.11.002","article-title":"Potential risks of glucagon stimulation test in elderly people","volume":"25","author":"Tavares","year":"2015","journal-title":"Growth Horm IGF Res"},{"key":"10.4158\/EP161407.DSCR_bb0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4158\/EP11146.OR","article-title":"Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests","volume":"18","author":"Toogood","year":"2012","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161407.DSCR_bb0230","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11102-015-0666-1","article-title":"Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?","volume":"18","author":"Diri","year":"2015","journal-title":"Pituitary"},{"key":"10.4158\/EP161407.DSCR_bb0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/314279a0","article-title":"Independent effects of growth hormone releasing factor on growth hormone release and gene transcription","volume":"314","author":"Barinaga","year":"1985","journal-title":"Nature"},{"key":"10.4158\/EP161407.DSCR_bb0240","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/jcem-67-6-1186","article-title":"Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion","volume":"67","author":"Alba-Roth","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0245","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.2008-1333","article-title":"The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men","volume":"93","author":"Makimura","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0250","first-page":"1615","article-title":"Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults","volume":"83","author":"Aimaretti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/ENDO:15:1:029","article-title":"Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults","volume":"15","author":"Ghigo","year":"2001","journal-title":"Endocrine"},{"key":"10.4158\/EP161407.DSCR_bb0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2265.2008.03359.x","article-title":"Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency)","volume":"70","author":"Darzy","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161407.DSCR_bb0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0270","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2004-1450","article-title":"Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests","volume":"90","author":"Qu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/JPEM.1993.6.1.21","article-title":"GH releasing peptides--structure and kinetics","volume":"6","author":"Bowers","year":"1993","journal-title":"J Pediatr Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-0115(02)00012-5","article-title":"Ghrelin--not just another stomach hormone","volume":"105","author":"Wang","year":"2002","journal-title":"Regul Pept"},{"key":"10.4158\/EP161407.DSCR_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-07-0066","article-title":"A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency","volume":"157","author":"Chihara","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0290","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1507\/endocrj.EJ12-0230","article-title":"The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison","volume":"60","author":"Kinoshita","year":"2013","journal-title":"Endocr J"},{"key":"10.4158\/EP161407.DSCR_bb0295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0029-1243184","article-title":"Diagnosis of adrenal insufficiency using the GHRP-6 Test: comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease","volume":"42","author":"Alaioubi","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.4158\/EP161407.DSCR_bb0300","first-page":"2633","article-title":"Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test","volume":"84","author":"Gasperi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/EJE-12-0584","article-title":"Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults","volume":"168","author":"Gasco","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161407.DSCR_bb0310","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2013-1157","article-title":"Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency","volume":"98","author":"Garcia","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0315","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1210\/jcem.87.5.8485","article-title":"The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6","volume":"87","author":"Popovic","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161407.DSCR_bb0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ecl.2014.10.003","article-title":"Pitfalls of insulin-like growth factor-i and growth hormone assays","volume":"44","author":"Junnila","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP161407.DSCR_bb0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","article-title":"Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays","volume":"57","author":"Clemmons","year":"2011","journal-title":"Clin Chem"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:00:24Z","timestamp":1761516024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20355762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1530891X20355762"],"URL":"https:\/\/doi.org\/10.4158\/ep161407.dscr","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726504095.793528639","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726504095.793538650","asserted-by":"object"}]},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: Update on Growth Hormone Stimulation Testing and Proposed Revised Cut-Point for the Glucagon Stimulation Test in the Diagnosis Of Adult Growth Hormone Deficiency","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161407.DSCR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}